How sham patents are hurting the pharma industry
The FTC is cracking down on pharma companies filing sham patents in the Orange Book to delay generics competition.
The FTC is cracking down on pharma companies filing sham patents in the Orange Book to delay generics competition.
At the London Biotechnology Show, Microsoft’s senior director of life sciences discussed the ethical use of GenAI.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
AstraZeneca to withdraw Covid-19 vaccine globally
GSK, Lundbeck, ROVI: Three Journeys of Unified Pharma Events Management
NIH team develops AI tool to predict cancer drug response
TetraScience and Google Cloud link for AI-driven drug developments